Zhang Chen and the two returned to the company from Shaocheng University.

At this time, Tian Wenbin and Jiang Lu came to find Zhang Chen together.

"Zhang Chen, our animal experiment data is out!"

Tian Wenbin began to roar when he met, completely losing his usual stability as a researcher.

Jiang Lu couldn't hide the excitement on his face.

He said excitedly: "Zhang Chen, you said before that you want to speed up the progress of the experiment at any cost, and for all the verification of animal experiments, I chose mouse, rabbit and monkey experiments to be carried out at the same time, and I also selected four service outsourcing companies to carry out the experiments simultaneously, so the final results are available today." ”

"How did it turn out?"

Zhang Chen smiled slightly, there was no wave in his heart, he had already expected the results of the experiment.

If there is a deviation in the final data, it means that Tian Wenbin and Jiang Lu have a problem, or the service outsourcing company they cooperate with has a problem.

The information provided by Zhang Chen, but the full set of production process data produced by the system, it is impossible to have problems at all.

"First of all, the four service outsourcing companies I found all have GLP certified laboratories and animal laboratories, and all experiments are carried out in strict accordance with national requirements."

Jiang Lu said quickly: "First of all, the toxicity test of the drug, whether it is in vitro or in vivo experiment, the final result is a perfect proof that this drug is very safe and does not have any drug toxicity and side effects.

Then there are the efficacy and pharmacokinetic experiments, and I was very surprised by the data in this regard, the therapeutic effect of this drug is completely unexpected, the drug metabolism is also very fast, and the onset time of the drug is less than half an hour.

In the end, on the whole, the preclinical safety and effectiveness evaluation of this drug completely exceeds any drug I know, and I am talking about all drugs, including chemical drugs and protein drugs, and even some small nucleic acid drugs in the clinical stage cannot be compared with this drug. ”

Zhang Chen nodded, his expression still indifferent.

Tian Wenbin was not very excited to see him, and was a little surprised.

"Zhang Chen, do you know what Lao Jiang represents?"

"I know all this, the effect of this drug should be like this, if the data is not good, there is a problem."

After Zhang Chen heard that there was no major problem with the experimental data, he was actually quite happy in his heart.

He was secretly glad in his heart, fortunately he recruited Tian Wenbin and Jiang Lu, otherwise the experiment might not have progressed so smoothly.

"In this case, in a few days, after we have all the materials ready, we can directly submit the CDE application for clinical trial," Jiang Lu said with a deep sigh, "The approximate time should be August 17 or 18." ”

"Okay, Tian Bo, Jiang Bo, thank you for your hard work, in this way, we can produce the drugs to be used in clinical trials in advance, and at the same time, I will have people recruit clinical trial volunteers."

In fact, Zhang Chen is not worried about the lack of volunteers at all, and there will definitely be many volunteers who will be tested at the People's Hospital in Shaocheng.

No matter how bad it is, you can ask Xu Zeming for help and let the hospitals in the capital participate.

The next day, August 14th.

At eight o'clock in the morning, Zhang Chen was ready to go to Bangsheng to attend the gene therapy drug research summit.

When he thought of Bangsheng, Zhang Chen didn't feel that he wanted to take the lovely employees to team building.

However, you can wait a few more days, and it is not too late to wait until "Lanyue 001" is declared for clinical trials.

No matter how fast the approval of clinical trials is, it will definitely take some time.

Just take advantage of this unbusy time period to let all employees relax and get to know each other.

Now that the scale of the company is getting bigger and bigger, Zhang Chen no longer insists on calling everyone's names.

But if you see the employees to get to know each other, don't be a stranger, and if there is a misunderstanding at that time, it will be a joke.

After Zhang Chen cleaned up briefly, he and Tian Wenbin set off for Bangsheng together.

Jiang Lu did not go because he had to prepare the application materials for the clinical trial.

Now when Zhang Chen goes out, he will recall "Guardian No. 1" back to the system and keep him on standby at any time.

In addition, it will be exchanged for two intermediate-grade [Strength Quick-Acting Capsules], ready to respond to emergencies at any time.

When they came to Bangsheng and handed over the car keys to the waiter, Zhang Chen and Tian Wenbin walked into the summit site.

Zhang Chen does not plan to speak on stage today.

He planned to ask Tian Wenbin to briefly introduce the drug efficacy and progress of the "Lanyue 001" project.

Seeing Zhang Chen's arrival, many CEOs of biological companies who knew him began to greet him.

To Zhang Chen's surprise, Zhao Yingbo, director of cardiac surgery at the People's Hospital, was also there.

What is he doing at such a meeting?

Zhao Yingbo began to greet Zhang Chen warmly from afar.

Zhang Chen even saw Zhou Qingfang, who was sitting on a chair in the third row with a middle-aged man.

This middle-aged man is probably his new boss.

The conference receptionist guided Zhang Chen and the two to the first row.

This made Zhang Chen speechless, the first row was a little too conspicuous, and the position was still in the middle of the first row.

In the future, it is better to participate in this kind of meeting as little as possible, such an appearance is completely inconsistent with his low-key character.

After Zhang Chen and the two sat down, Zhou Qingfang and his boss came to the two.

For Zhou Qingfang, Tian Wenbin doesn't have much idea now.

After all, if it weren't for Zhou Qingfang's boost, he wouldn't have come to Chenyue Biology so soon, so he would probably miss such a good project as "Lanyue 001".

To some extent, I also need to thank Zhou Qingfang.

And Zhang Chen still ignored Zhou Qingfang, but chatted a little more with his new boss.

After Zhou Qingfang and the two left, the meeting was about to start.

At this time, Li Bozhan came to the venue, and he walked straight to the position next to Zhang Chen and sat down.

This made everyone present look at Zhang Chen with admiration again.

How can a character who can be on an equal footing with Academician Li Bozhan be a small role?

Originally, some people who didn't know Zhang Chen very well said that they wanted to get to know Zhang Chen after the meeting.

After Zhang Chen and the three of them chatted casually for a while, the meeting officially began.

According to the process of the meeting, the first is Li Bozhan's opening speech.

Elder Li came to the podium and finished his more formal speech.

In the end, he also specifically mentioned Zhang Chen, unabashedly praised Zhang Chen, and also revealed a little bit about Chenyue biological gene therapy drugs.

This whetted everyone's appetite, especially those who knew about the creatures of the Morning Moon for the first time.

Everyone present is all people in the industry, and Li Bozhan mentioned it a little, and he knew how difficult it was for Chenyue Biology to do it now.

In fact, there are many targets of gene therapy drugs, but the least difficult to scientific research is some ophthalmic diseases and liver diseases.

Few or few companies have the courage to directly use internal treatment methods to overcome blood diseases.

For most of the hematological diseases, in vitro cell therapy is the most effective method.

The blood disease treatment drug in vivo of Chenyue Biology is also a gene therapy drug, which can be said to be the only one in the country.